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Guidelines

PROSPECT guideline for total hip arthroplasty: a systematic
review and procedure-speciﬁc postoperative pain
management recommendations
M. Anger,1 T. Valovska,2 H. Beloeil,3 P. Lirk,4 G. P. Joshi,5 M. Van de Velde,6,7 J. Raeder,8,9 on
behalf of the PROSPECT Working Group* and the European Society of Regional Anaesthesia
and Pain Therapy
1 Consultant, 3 Professor, Service d’Anesthesie Reanimation et Medecine Peri-operatoire, Universite Rennes, Rennes,
France
2 Resident, Department of Anesthesiology, Henry Ford Health Systems, Wayne State School of Medicine, Detroit, MI, USA
4 Associate Professor, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston,
MA, USA
5 Professor, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center,
Dallas, TX, USA
6 Professor, Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, 7 Professor, Department of
Anaesthesiology, UZLeuven, Leuven, Belgium
8 Professor, Department of Anaesthesiology, Oslo University Hospital, Oslo, 9 Professor, Division of Clinical Medicine,
University of Oslo, Oslo, Norway

Summary
The aim of this systematic review was to develop recommendations for the management of postoperative pain
after primary elective total hip arthroplasty, updating the previous procedure-speciﬁc postoperative pain
management (PROSPECT) guidelines published in 2005 and updated in July 2010. Randomised controlled
trials and meta-analyses published between July 2010 and December 2019 assessing postoperative pain using
analgesic, anaesthetic, surgical or other interventions were identiﬁed from MEDLINE, Embase and Cochrane
databases. Five hundred and twenty studies were initially identiﬁed, of which 108 randomised trials and 21
meta-analyses met the inclusion criteria. Peri-operative interventions that improved postoperative pain include:
paracetamol; cyclo-oxygenase-2-selective inhibitors; non-steroidal anti-inﬂammatory drugs; and intravenous
dexamethasone. In addition, peripheral nerve blocks (femoral nerve block; lumbar plexus block; fascia iliaca
block), single-shot local inﬁltration analgesia, intrathecal morphine and epidural analgesia also improved pain.
Limited or inconsistent evidence was found for all other approaches evaluated. Surgical and anaesthetic
techniques appear to have a minor impact on postoperative pain, and thus their choice should be based on
criteria other than pain. In summary, the analgesic regimen for total hip arthroplasty should include preoperative or intra-operative paracetamol and cyclo-oxygenase-2-selective inhibitors or non-steroidal antiinﬂammatory drugs, continued postoperatively with opioids used as rescue analgesics. In addition, intraoperative intravenous dexamethasone 8–10 mg is recommended. Regional analgesic techniques such as fascia
iliaca block or local inﬁltration analgesia are recommended, especially if there are contra-indications to basic
analgesics and/or in patients with high expected postoperative pain. Epidural analgesia, femoral nerve block,
lumbar plexus block and gabapentinoid administration are not recommended as the adverse effects outweigh
the beneﬁts. Although intrathecal morphine 0.1 mg can be used, the PROSPECT group emphasises the risks
and side-effects associated with its use and provides evidence that adequate analgesia may be achieved with
basic analgesics and regional techniques without intrathecal morphine.
.................................................................................................................................................................
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Recommendations
1
2

Pre-operative

exercise

and

education

are

How does this guideline differ from
other guidelines?

recommended.

The present guideline applies the updated procedure-

The basic analgesic regimen should include a

speciﬁc postoperative pain management (PROSPECT)

combination of paracetamol and a non-steroidal anti-

methodology

inﬂammatory drug or a cyclo-oxygenase-2-selective

literature. It considers the analgesic beneﬁt of interventions

inhibitor

against the backdrop of basic analgesics (i.e. paracetamol

administered

pre-operatively

or

intra-

that

critically

evaluates

the

available

operatively and continued postoperatively.

and non-steroidal anti-inﬂammatory drugs (NSAIDs) or

3

Spinal or general anaesthesia is recommended.

cyclo-oxygenase-2

4

A

5
6

inhibitors)

and

intravenous

balances the procedure-speciﬁc efﬁcacy and beneﬁts of an

dexamethasone 8–10 mg is recommended for its

intervention against its general risks and invasiveness. In

analgesic and anti-emetic effects.

that sense, it is more clinically applicable and pragmatic

A single-shot fascia iliaca block or local inﬁltration

than statistical analysis used in meta-analyses, as well as

analgesia is recommended.

focused on pain rather than overall enhanced recovery after

single

intra-operative

dose

of

If the patient has received spinal anaesthesia for the
surgery,

7

(COX-2)-selective

intrathecal

morphine

0.1 mg

could

surgery (ERAS) pathways or anaesthetic techniques.

be

considered.

Introduction

Opioids should be reserved as rescue analgesics in the

Total hip arthroplasty is a common surgical procedure aiming

postoperative period.

to improve mobility and quality of life in patients suffering from
hip pain [1]. Adequate analgesia with minimal side-effects

Why was this guideline developed?

allows for early postoperative mobility, optimal functional

Total hip arthroplasty is a common surgical procedure and

recovery and decreased postoperative morbidity [2]. Despite

is associated with signiﬁcant postoperative pain. Pain

being a frequently performed surgical procedure, there is

control can facilitate early postoperative rehabilitation,

high variability in the peri-operative anaesthetic and analgesic

which

recent

management for total hip arthroplasty [3, 4]. Recent guidelines

guidelines. The aim of this guideline is to provide clinicians

have focused on ERAS [4] or anaesthetic technique [5] and

with an updated evidence-based approach to pain

those speciﬁcally assessing peri-operative pain management

management for elective total hip arthroplasty.

do not address all possible analgesic interventions in a single

is

being

increasingly

encouraged

in

document [6, 7]. Also, for some recommendations [3–7] a

What other guidelines are available on
this topic?

detailed approach to the systematic review of literature is not

Several guidelines have been published assessing peri-

included randomised controlled trials, such as the efﬁcacy

operative care in total hip arthroplasty. However, some are

when evidence-based basic simple analgesia had been

focused on enhanced recovery after surgery or anaesthetic

included as active comparators [2]. One guideline is not

technique, and those speciﬁcally assessing peri-operative

updated [6].

pain management focus on the efﬁcacy of single

provided, and lacks scientiﬁc discussion on the design of

The

PROSPECT

Working

Group

is

a

global

interventions, broad techniques (e.g. regional analgesic

collaboration of surgeons and anaesthetists formulating

techniques) or speciﬁc opioid-sparing strategies.

procedure-speciﬁc

2

recommendations

for

pain
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painful

deﬁned a change of more than 10 mm on the visual

operations [8]. The recommendations are based on a

analogue scale (VAS) or one point on a numerical rating

procedure-speciﬁc

of

score as clinically relevant [12]. Also statistically signiﬁcant

randomised controlled trials and systematic reviews. The

differences in analgesic opioid rescue medication or

methodology also considers clinical practice, efﬁcacy and

in opioid induced side-effects were used as valid

adverse effects of analgesic drugs and techniques in order

outcomes.

management

after

common

but

systematic

potentially

literature

review

For recommending an analgesic, at least two

to provide overall recommendations [9].
The PROSPECT group has previously published a

randomised controlled trials have to show efﬁcacy. In

review on total hip arthroplasty in 2005 [10] that was

addition, the efﬁcacy of the analgesic intervention over the

updated in 2010 [11]. Of note, the previous update included

use of basic analgesics (paracetamol and NSAIDs or COX-2-

the literature search from 1966 to July 2010 [11]. The aim of

selective inhibitors) was also considered. Furthermore,

the present systematic review was to update the 2010

adverse effects and clinical aspects were evaluated. A sub-

recommendations using the recently modiﬁed PROSPECT

group developed draft recommendations, which were then

methodology [9], focusing on postoperative pain outcomes

circulated amongst all the members for review and

while assessing the effects of analgesic interventions in

comments. A modiﬁed Delphi approach was utilised as

reference to the use of basic analgesics (paracetamol and

previously described [9]. This included obtaining feedback

NSAIDs or COX-2-selective inhibitors) and balancing risks

from PROSPECT members via email, followed by revised

and beneﬁts of analgesic strategies.

drafts of recommendations. This was followed by face-toface discussions with the aim of developing a consensus.

Methods

For conﬂicting recommendations, members voted via

The methods of this review adhered to the PROSPECT

email. Once the members had opined, the lead authors

methodology as previously reported [9]. Speciﬁc to this

drafted the ﬁnal manuscript, which was ultimately approved

study, the Embase, MEDLINE, PubMed and Cochrane

by the full PROSPECT group.

Databases were searched for randomised controlled trials
published between July 2010 and December 2019. The

Results

search terms related to pain and total hip arthroplasty

A total of 108 randomised controlled trials and 21 meta-

included: "replacement" OR "prosthesis" OR "arthroplasty"

analyses were included for the ﬁnal qualitative analysis

AND "hip" AND "postoperative pain" OR "pain" OR "pain

(Fig. 1).

scale" or "rehabilitation" OR " pain management" OR

interventions are given in Table 1 and interventions that are

"epidural" OR "spinal" OR "intrathecal anaesthesia" OR

not

"peripheral nerve block" OR "nerve block" OR "local

methodological quality assessments of the randomised

anaesthetics" OR "regional anaesthesia" OR "regional

controlled trials are summarised in online Supporting

analgesia" OR "plexus block" OR "nerve block" OR

Information Table S1. The characteristics of the included

"inﬁltration" OR "local inﬁltration analgesia" OR "lidocaine"

studies are shown in online Supporting Information

OR "nonsteroidal anti-inﬂammatory drugs (NSAIDs)" OR

Tables S2 and S3.

Summary

recommended

recommendations
are

listed

in

on

analgesic

Table 2.

The

"NSAIDs" OR "non-opioid analgesic" OR "opioid" OR
"opioids" OR "dexamethasone" OR "gabapentin" OR

Pre-operative interventions

"pregabalin"

OR

A single study assessed the effects of carbohydrate

"acetaminophen" OR "nefopam" OR "COX 2 selective

loading on postoperative pain and fatigue in hip

inhibitor" OR "COX 2 inhibitor" OR "clonidine". We

arthroplasty patients [13], demonstrating a signiﬁcant

excluded any studies on acute hip fracture.

reduction of postoperative pain for the ﬁrst 20 h following

OR

"ketamine"

OR

"paracetamol"

Only studies reporting either pain scores (verbal or

surgery. In a study by Goyal et al., the effect of

numerical) or opioid consumption were included [9].

management status (i.e. inpatient vs. day-case total hip

Systematic reviews and meta-analyses, when available,

arthroplasty)

were used to check for studies not identiﬁed in our

protocols was considered [14]. Postoperative pain was

database search. Quality assessment of eligible studies was

signiﬁcantly lower in day-case patients but this was not

made according to PROSPECT methodology [9]. In brief,

clinically signiﬁcant. Pre-operative exercise and education

this involved a grading of allocation concealment (A–D);

were

Jadad score (1–5); adequacy of statistical reporting (yes or

postoperative pain and improving functional outcomes in

no); and level of evidence (1–4). In the present report, we

a meta-analysis conducted by Moyer et al. [15].

© 2021 Association of Anaesthetists

both

with

found

similar

to

be

postoperative

beneﬁcial

in

analgesic

reducing
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Figure 1 Flow diagram of studies identiﬁed, screened and included in this systematic review. VAS, visual analogue scale.

Table 1 Overall recommendations for pain management
in patients undergoing total hip arthroplasty.
Pre-operative and intra-operative

Basic systemic non-opioid analgesics
Intravenous (i.v.) paracetamol was compared with placebo
in two studies [16, 17], which showed lower pain intensity

Pre-operative exercise and education (Grade A)

scores over the ﬁrst 24 h and lower morphine consumption

General or spinal anaesthesia (Grade A)

in the paracetamol groups. Westrich et al. [18] found no

Paracetamol (Grade A)

difference

Non-steroidal anti-inﬂammatory drugs or cyclo-oxygenase-2selective inhibitors (Grade A)

between

i.v.

vs.

oral

administration

of

paracetamol on postoperative pain outcomes. Paracetamol,
anti-inﬂammatory drugs and placebo were recently

Dexamethasone 8–10 mg i.v. (Grade A)

compared in two studies. When taken individually, both

Single-shot fascia iliaca block or local inﬁltration analgesia
(Grade D)

drugs improved postoperative pain outcomes, whereas

If the patient has received spinal anaesthesia for the surgery,
intrathecal morphine 0.1 mg could be considered (Grade D)

over parecoxib alone in one study [19], and paracetamol

Postoperative
Paracetamol (Grade A)
Non-steroidal anti-inﬂammatory drugs or cyclo-oxygenase-2selective inhibitors (Grade A)
Opioid for rescue (Grade D)

4

parecoxib plus paracetamol did not improve pain scores
combined with ibuprofen did not result in a clinically
relevant improvement over ibuprofen alone [20]. This
suggests a limited impact of paracetamol when added to a
regimen including COX-2-selective inhibitors or NSAIDs,
but paracetamol is recommended as part of basic
postoperative

analgesia

in

general,

due

to

minor

© 2021 Association of Anaesthetists
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Table 2 Analgesic interventions that are not recommended for pain management in patients undergoing total hip arthroplasty.

Pre-operative
or intra-operative

Postoperative

Surgical technique

Intervention

Reason for not recommending

Carbohydrate loading

Limited procedure-speciﬁc evidence

Outpatient status

Limited procedure-speciﬁc evidence

Pre-incisional COX-2-selective
inhibitor vs. post-incisional

Limited procedure-speciﬁc evidence

Gabapentinoids

Inconsistent evidence for single-dose.
Procedure-speciﬁc evidence for multiple
peri-operative doses, but extra side-effects

Ketamine

Limited procedure-speciﬁc evidence

Lateral femoral cutaneous block

Limited procedure-speciﬁc evidence

Anterior quadratus lumborum block

Limited procedure-speciﬁc evidence

Femoral nerve block

Procedure-speciﬁc evidence, but side-effects

Lumbar plexus block

Procedure-speciﬁc evidence, but side-effects

LIA adjuncts to local anaesthesia drugs

Inconsistent procedure-speciﬁc evidence

LIA infusion or repeated injections

Inconsistent procedure-speciﬁc evidence

Epidural analgesia

Procedure-speciﬁc evidence, but side-effects

Tranexamic acid

Lack of procedure-speciﬁc evidence

Partial weight bearing

Lack of procedure-speciﬁc evidence

Topical ﬁbrin sealant

Lack of procedure-speciﬁc evidence

TENS

Limited procedure-speciﬁc evidence

Anterior approach vs. posterolateral approach

Inconsistent procedure-speciﬁc evidence

Minimally invasive vs. traditional incision

Inconsistent procedure-speciﬁc evidence, increased risks

LIA, local inﬁltration analgesia; TENS, transcutaneous electrical nerve stimulation.

i.v.

were not found in another study with a 30-min pre-incisional

paracetamol with i.v. metamizole and found clinically

i.v. parecoxib infusion [28]. Moreover, one study directly

insigniﬁcant reductions in morphine consumption and pain

compared 30-min pre- vs. 30-min post-incisional i.v. 40 mg

scores with metamizole [21], although pain scores in both

parecoxib administration [25] and found lower pain scores

groups were always lower than 40 mm on a VAS.

up to 6 h postoperatively and lower morphine consumption

side-effects.

Finally,

a

single

study

compared

Three studies showed analgesic beneﬁt of NSAID

up to 24 h postoperatively with a pre-incisional protocol.

and

In conclusion, and in keeping with the PROSPECT basic

orphenadrine infusions after surgery and at 12 h reduced

analgesia recommendation [9], the administration of

morphine patient-controlled analgesia (PCA) consumption

paracetamol in combination with NSAID or COX-2-selective

postoperatively [22]. McQuay et al. [23] showed that a

inhibitors is recommended for total hip arthroplasty patients

combination of oral dexketoprofen 25 mg with tramadol

unless contraindicated. There is insufﬁcient evidence to

75 mg was superior to both medications alone for

determine whether pre-operative COX-2 administration has

postoperative pain control. In a three-group study,

an advantage over postoperative COX-2 administration.

ketorolac

There is no procedure-speciﬁc evidence to choose a

administration

[22–24].

improved

Regular

pain

i.v.

scores

diclofenac

and

morphine

consumption compared with a novel protein kinase C-

speciﬁc NSAID or COX-2-selective inhibitor.

epsilon inhibitor and placebo [24].
Four studies [25–28] speciﬁcally assessed controlling

Analgesic non-opioid adjuncts

postoperative pain with pre-incisional COX-2-selective

Six studies showed a beneﬁt on postoperative pain

inhibitor administration. Two studies found that oral

outcomes with glucocorticoid use [29–34]. Peri-operative

etoricoxib 2 h before surgery [26], or i.v. parecoxib or oral

125 mg methylprednisolone compared with placebo

celecoxib 1 h before surgery [27] were associated with

reduced 24-h pain scores [31]. A second study showed

signiﬁcantly lower postoperative pain scores and morphine

analgesic beneﬁt from 20 mg prednisolone pre-operatively

consumption when compared with placebo. These beneﬁts

followed by two postoperative doses of i.v. hydrocortisone

© 2021 Association of Anaesthetists
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administered 8 h apart in patients with patient-controlled

combination of pregabalin and ketamine or placebo [44].

epidural analgesia, while pain scores did not differ [30].

However, no basic analgesia was used. Both ketamine

Backes et al. [29] demonstrated that 10 mg of peri-

and pregabalin signiﬁcantly reduced 48-h morphine

operative dexamethasone had a signiﬁcant effect, reducing

consumption with no difference in pain scores and side-

mean VAS pain scores by > 20 mm, reducing opioid

effects (nausea; pruritus; dizziness). This sole study is

consumption in the ﬁrst 24 h, with early ambulation and a

insufﬁcient

shorter length of hospital stay. An additional dose of 10 mg

ketamine or single-dose pregabalin.

evidence

to

recommend

peri-operative

dexamethasone at the postoperative 24-h mark showed
continued effect, with lower morphine consumption on day

Anaesthetic technique

two and a shorter length of stay when compared with a

The PROSPECT Group has previously recommended that

single

was

the anaesthetic technique should not be selected solely for

demonstrated on top of adequate basic analgesia [32–34]

its effects on postoperative pain or opioid consumption

showing improved postoperative pain outcomes with 8 or

[11]. However, three studies examining the effect of choice

10 mg, a lower incidence of postoperative nausea and

of anaesthetic technique are included in this review.

vomiting and a shorter length of stay. Three meta-analyses

General anaesthesia with a total i.v. anaesthesia approach

showed beneﬁts from glucocorticoids use on postoperative

was compared with spinal anaesthesia in a 120-patient

pain outcomes; time to discharge; and postoperative

study using adequate basic analgesia [45]. Results showed

nausea and vomiting [35–37]; No major adverse events

that patients receiving general anaesthesia had signiﬁcantly

were described in these studies, other than a small but

higher pain scores during the ﬁrst 2 postoperative hours but

signiﬁcant increase in blood glucose concentration in

lower after 6 h compared with the spinal anaesthesia group.

diabetic patients when dexamethasone was used [29,32].

A second study [46] showed lower VAS pain scores and

The occurrence of postoperative infection did not differ [34,

morphine consumption up to 24 h postoperatively with

35].

spinal or epidural vs. general anaesthesia but adequate

dose.

The

efﬁcacy

of

dexamethasone

sole

basic analgesia was not used. Mei et al. investigated the

intervention, Paul et al. found no analgesic beneﬁt when

efﬁcacy of dexmedetomidine or propofol as sedatives in

gabapentin 600 mg was administered pre-operatively

addition to regional anaesthesia and found no difference in

followed up by a regimen of 200 mg three times daily

pain outcomes, but a lower risk of delirium in the

for 3 days postoperatively [38]. However, Clarke et al.

dexmedetomidine group [47]. In a recent meta-analysis,

showed

pregabalin

Yang et al. [48] showed signiﬁcantly less pain when

150 mg administration continued postoperatively when

dexmedetomidine was part of the anaesthetic protocol.

added to a basic analgesic regimen of celecoxib and

However, the reduction in pain in the studies on total hip

morphine PCA [39]. Carmichael et al. [40] investigated

arthroplasty was small, and bradycardia was reported as a

the combination of celecoxib and pregabalin (75 mg

signiﬁcant and frequent side-effect with dexmedetomidine.

When

twice

considering

effectiveness

daily)

for

gabapentinoids

of

as

the

pre-operative

2 weeks

preceding

and

3 weeks

In conclusion, there is insufﬁcient evidence to support a

in

the

speciﬁc anaesthetic technique in favour of another in terms

pain

on

of postoperative analgesic beneﬁts, although spinal

postoperative day one. However, morphine consumption

anaesthesia may positively inﬂuence other postoperative

did not differ, and there were more side-effects in the

outcomes when compared with general anaesthesia [5].

following

surgery

and

found

that

patients

treatment

group

experienced

less

acute

pregabalin-celecoxib group. The three meta-analyses
included

assessing

the

efﬁcacy

of

gabapentin

or

Peripheral nerve block

pregabalin [41–43] in total hip arthroplasty found

Single-shot peripheral nerve blocks have previously been

morphine-sparing effects, but reported side-effects such

recommended by the PROSPECT Group for total hip

as dizziness, and were inconsistent regarding pain

arthroplasty without further speciﬁcation regarding the

reduction.

In

operative

gabapentinoids

reduction

but

conclusion,
are

not

doses

of

peri-

type of blocks [11]. Twenty-six new studies were available

evidence

of

pain

for review on this topic: 22 randomised controlled trials

routine

and four meta-analyses. The interventions studied were:

repeated
show

recommended

as

femoral

medication due to clinically relevant side-effects.
The
pregabalin

efﬁcacy
was

of

intra-operative

compared

in

consisting of ketamine alone,
6

a

ketamine

four-group

nerve

block;

lumbar

plexus

block;

psoas

vs.

compartment block; fascia iliaca block; lateral femoral

study

cutaneous nerve block; and anterior quadratus lumborum

pregabalin alone, a

block.
© 2021 Association of Anaesthetists
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postoperative analgesia. When compared with no block
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effect on postoperative pain outcomes over placebo in a
report from Bron et al. [66].

with adequate basic analgesia, Kratz et al. showed that

Six studies evaluated lumbar plexus block [67–72].

single-shot femoral nerve block signiﬁcantly improved pain

When compared with LIA [67, 68], lumbar plexus block

scores and reduced analgesic consumption, despite a high

did not show any beneﬁt on postoperative pain and

dropout rate [52]. In another study, patients receiving a

opioid consumption. Local inﬁltration analgesia had lower

femoral nerve block met earlier post-anaesthesia care unit

pain scores at 3 h postoperatively in one study [67].

(PACU) discharge criteria, with lower pain scores and

Continuous lumbar plexus block was compared with

analgesic consumption [51]. Continuous femoral nerve

paravertebral block performed at L2 by Wardhan et al.

block was also compared with lumbar plexus block [49] and

[70]. Morphine consumption during the ﬁrst 24 h was

with epidural analgesia [54]. Similar pain and analgesic

higher in the paravertebral block group, but pain scores

requirements were reported. When femoral nerve block

were similar. When lumbar plexus block was compared

was compared with fascia iliaca block, pain scores were

with 0.1 mg intrathecal morphine [72], patients in the

higher in the femoral nerve block group (but only by 5 mm

latter group required less intra-operative opioids, less

with both groups being < 15 mm on the VAS) [50]. Kuchalik

rescue morphine and had lower pain scores in PACU.

et al. [53] showed that femoral nerve block proved inferior

However, they needed more rescue morphine in the

to local inﬁltration analgesia (LIA) for the ﬁrst 24

subsequent 24 h and experienced increased pruritus.

postoperative hours on pain scores and morphine

Also, ropivacaine 0.1% and 0.2% continuous lumbar

consumption, and with signiﬁcantly more motor blockade in

plexus

femoral nerve block group.

demonstrated similar pain outcomes and motor block

block

have

been

compared

[71],

which

Fascia iliaca block was evaluated in six studies [55–60].

intensity. Lastly, Green et al. [69] considered an intra-

Shariat et al. [55] used fascia iliaca block as rescue analgesia

operative, surgeon-delivered psoas compartment block

in PACU, reporting that it did not improve pain scores or

performed during total hip arthroplasty vs. no block.

morphine consumption vs. placebo. However, another

Psoas compartment block prolonged the time to ﬁrst

study

request of rescue analgesia and reduced postoperative

showed

clinically

relevant

signiﬁcantly

lower

morphine consumption at 24 and 48 h with a fascia iliaca

pain scores.

block compared with no block on top of multimodal basic

One study evaluated an anterior quadratus lumborum

analgesia [56]. Comparing fascia iliaca block with

block compared with no block [73]. Patients in the treatment

alternative anaesthetic techniques, Kearns et al. [57]

group showed lower morphine consumption and lower

showed that morphine consumption was higher with fascia

pain scores at 24 h, but not at other time-points.

iliaca block when compared with 0.1 mg intrathecal

In conclusion, femoral nerve block, lumbar plexus

morphine, with no difference in pain scores or side-effects

block, psoas compartment block, quadratus lumborum

apart from 2 h shorter time to mobilisation in the fascia iliaca

block and fascia iliaca block lowered postoperative pain

block group. Perry et al. [60] found similar data between

scores and morphine consumption, whereas lateral femoral

fascia iliaca block and psoas compartment block. When

cutaneous block did not. At the time of our search, we only

compared with LIA [58, 59], postoperative pain outcomes

found one randomised controlled trial on quadratus

did not differ; however the fascia iliaca block group showed

lumborum block. The lumbar plexus block is a deep block

more muscle weakness at 6 h in one study [58]. Finally, three

with potential risks [74] and the femoral nerve block has a

recent meta-analyses [61–63], combining the existing data,

signiﬁcant incidence of muscle weakness [74, 75], and are

all concluded that there was lower pain scores, lower

thus not recommended. The potential beneﬁt of nerve

morphine consumption and even shorter length of stay

blocks on postoperative pain should be balanced against

when fascia iliaca block was used, with no greater risk of falls

the side-effects, such as delayed mobilisation, motor block

[61].

or risk of falls. In recent meta-analyses, no more falls were
Thybo et al. performed two studies on lateral femoral

reported with fascia iliaca block [61, 62], which is

cutaneous block compared with placebo with adequate

recommended as the preferred nerve block when a nerve

baseline multimodal analgesia [64, 65]. One study did not

block is indicated for total hip arthroplasty.

show any difference in pain scores [65], the other showed
that lateral femoral cutaneous block reduced movement-

Local inﬁltration analgesia

related pain [64]. A double nerve block of lateral femoral

Local inﬁltration analgesia was not part of previous

cutaneous block and subcostal nerves via inﬁltration had no

PROSPECT recommendations, primarily due to inadequate

© 2021 Association of Anaesthetists
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evidence. For the present review, single-injection LIA was

experienced more postoperative nausea and vomiting and

directly compared with placebo or no injection in 15

pruritus.

randomised controlled trials [76–90]. Of these, ﬁve placebo-

Three meta-analyses [104–106] indicated that multi-

controlled randomised controlled trials showed lower pain

drug LIA had lower postoperative pain scores, lower opioid

scores, opioid consumption or shorter length of stay [83, 84,

consumption and in one meta-analyses a shorter length of

86, 87, 89]. When compared with no injection, Busch et al.

hospital stay [105]. Comparing LIA, peripheral nerve block

[85] showed signiﬁcantly lower pain scores and morphine

and placebo in a network meta-analysis [107] including 35

consumption, but basic analgesia was not used. Villatte

randomised controlled trials and 2296 patients, the LIA

et al. [88] reported a difference in pain scores, but this was

treatment group had lower postoperative pain scores and

not clinically meaningful. Another seven randomised

opioid consumption at 24 h vs. placebo, whereas

controlled trials in which LIA was combined with adequate

peripheral nerve block failed to do the same. However,

basic analgesia failed to show improvements in pain control

there was no difference between peripheral nerve block

[76–82]. In the meta-analyses of Ma et al., LIA resulted in

and LIA on these outcomes. In conclusion, single-injection

signiﬁcant beneﬁts during the ﬁrst 24 h in terms of less pain

LIA has analgesic effect with no side-effects.

at rest and during movement, and a reduction in opioid
consumption [92]. When bupivacaine was compared with

Epidural analgesia

liposomal bupivacaine for LIA, there were similar pain

Epidural levobupivacaine with sufentanil adjuvant was

outcomes [93].

compared with oral controlled-release oxycodone [108].

Two studies assessing multiple doses or continuous

Epidural analgesia provided better dynamic pain relief

infusion of LIA compared with placebo [94, 95] found

(mean VAS reduction from 3.0 to 1.7 on a 0–10 scale) and

improved postoperative pain scores and morphine

lower opioid consumption on day one postoperatively.

consumption at 48–72 h with a pericapsular infusion via a

However, oral oxycodone was more effective on pain

catheter. However, a systemic effect of local anaesthesia

control at rest on postoperative days two and three. The

cannot be ruled out, and three studies with a similar design

modest differences in pain reduces the impact of these

failed to show any beneﬁt [96–98].

results.
regimen

Adjuvant epidural therapies were addressed in three

containing LIA and patient-controlled epidural analgesia,

studies [109–111]. The following had beneﬁcial effects on

pain scores during movement favoured the epidural

postoperative pain outcomes: 8 mg epidural dexamethasone

group. However, for the primary outcome of readiness for

[110], 75 mg epidural magnesium [109] and epidural

hospital discharge, there was no difference [99]. In a

ketamine [109, 111]; however, adequate basic analgesia was

three-group study [100] comparing a multi-drug LIA

not used in these studies.

When

comparing

a

multimodal

pain

regimen, morphine PCA and epidural analgesia, patients

In conclusion, epidural analgesia is effective, but is not

with LIA reported reduced pain scores and morphine

recommended due to well-recognised side-effects in lower

consumption compared with those receiving morphine

limb surgery, such as limb weakness, bladder dysfunction

PCA. No difference was observed when compared with

and delayed mobilisation [112].

epidural. Yan et al. [101] compared LIA with epidural in a
meta-analysis of nine studies and found no signiﬁcant

Spinal analgesia

difference between the LIA and the epidural group 48–

Seven studies [58, 73, 102, 103, 113–115] evaluated the

72 h after surgery for pain with movement, but less pain

effectiveness

at 24 h in the epidural group [101].

postoperative pain after total hip arthroplasty. Comparison

of

adding

intrathecal

analgesia

for

Two studies compared LIA with intrathecal morphine

of intrathecal morphine to peripheral nerve block [58, 73] or

0.1 mg [102, 103]. One study [102], found no differences in

LIA [102, 103] is discussed in previous paragraphs.

pain scores or postoperative nausea and vomiting.

Evaluating intrathecal morphine doses of 0.05 mg vs.

Although patients in the LIA group required more rescue

0.1 mg showed that patients receiving 0.1 mg had lower

oxycodone, they mobilised better at 6 h after surgery as

pain scores and a longer duration of analgesia [113] but use

well as the following morning [102]. The second study [103]

of basic analgesia was not reported. Similar postoperative

showed that intrathecal morphine was more effective in the

nausea and vomiting frequency was found in both groups,

ﬁrst 24 h compared with multi-drug LIA, but patients in this

but patients receiving the higher dose experienced pruritus

group had higher morphine consumption after 24 h and

more often.
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Intrathecal adjuvants have also been evaluated in two

In conclusion, there is inconclusive evidence in terms of

other studies [114, 115]. Intrathecal ketorolac 2 mg showed

postoperative pain for choosing a speciﬁc surgical

no beneﬁt on postoperative pain outcomes [114] but

approach. Thus, surgical technique should depend on

intrathecal or i.v. magnesium lowered pain scores and 24-h

surgeon and patient preference.

morphine consumption vs. no adjuvants [115].
In conclusion, when spinal anaesthesia is used for

Postoperative interventions

surgery, there is evidence for analgesic effect of intrathecal

Four studies evaluated postoperative opioid administration

morphine 0.1 mg, which could be considered.

[135–138]. Rothwell et al. showed that PCA with i.v.

Operative techniques

study found no differences in pain scores between i.v.

We included 16 randomised controlled trials and three meta-

morphine vs. a combination of i.v. oxycodone and morphine

analyses comparing surgical techniques. These interventions

[137]; while i.v. fentanyl showed lower pain scores and lower

morphine had no beneﬁts over oral oxycodone [135]. One

include drains [116–119]; different conventional surgical

morphine consumptions than i.v. oxycodone [138]. Lastly,

approaches [120–124]; and minimally invasive approaches

Musclow et al. examined the effectiveness of adding 30 mg

to hip arthroplasty [125–133]. Pain was a secondary outcome

oral

in most of these studies, and a basic analgesic regimen was

paracetamol/NSAIDs/morphine PCA regimen vs. placebo.

often inadequate or not speciﬁed. Considering the use of

Modiﬁed-release morphine did not prove effective on pain

modiﬁed-release

morphine

every

12 h

to

a

postoperative drains vs. no drains, pain scores were similar in

scores but was associated with signiﬁcantly more opioid-

both groups [116–118], but one study reported higher pain

related side-effects [136].

scores in the patients with a drain [119]. Thus, drains are not
recommended to improve pain outcomes.

Analgesic effects of several other postoperative
interventions have been examined. There were no clinical

Comparing the direct anterior surgical approach with

differences in pain outcomes between partial weight-

the posterolateral approach, three studies [120–122] found

bearing compared with full weight-bearing after cementless

lower pain scores with the direct anterior surgical approach

total hip arthroplasty [139]. Further, dressing type [140] or

on the ﬁrst postoperative day, but with less than 10-mm

topical administration of ﬁbrin sealant [141] did not make

difference on the VAS. Pooling these results and others, a

any

meta-analysis by Wang et al. [123], conﬁrmed direct anterior

transcutaneous electrical nerve stimulation showed a

surgical approach to be associated with less postoperative

reduction on postoperative fentanyl consumption at 24 h,

pain than a posterolateral approach to total hip arthroplasty,

but no effect on pain scores. Despite a reduction in blood

but was associated with a longer duration of surgery.

loss, tranexamic acid administration proved inconsistent on

Putananon et al. [124], showed that, despite experiencing

improving pain outcomes [143, 144].

difference.

A

single

study

[142]

examining

lower postoperative pain with a lateral vs. anterior vs.
posterior approach, surgical complications were seen more

Discussion

frequently in the same order, respectively.

This systematic review of total hip arthroplasty examined

Three studies supported improved postoperative pain

the effects of peri-operative analgesic, anaesthetic and

outcomes with a minimally invasive operative approach vs.

surgical techniques, as well as other interventions, on

conventional approach [125, 126, 132], but surgical

postoperative pain. The updated recommendations are

complications were more frequent in the minimally invasive

presented in Table 1. The strength of this study stems

approach group in one study [132]. However, ﬁve other

from the PROSPECT methodology [9], which goes

studies did not show any difference on postoperative pain

beyond making recommendations based on the simple

outcomes, comparing a minimally invasive approach to a

statistical analysis of the available evidence. The included

conventional approach [127–130, 133]. Finally, a meta-

studies are interpreted preferably based on the use of

analysis of 2849 patients [131] showed a clinically

basic analgesics (paracetamol with NSAIDs or COX-2-

insigniﬁcant beneﬁt on pain scores with the minimally

selective inhibitors) and balancing the beneﬁts and

invasive approach, but with a ﬁve-fold higher risk of

adverse effects of the intervention, as well as assimilating

iatrogenic nerve damage in this group when compared with

this information in a clinical context. More importantly,

a conventional approach.

signiﬁcant attention is given to the modern approach of

One study showed similar pain scores and morphine

early ambulation after total hip arthroplasty as well as

consumption comparing a bipolar sealer and standard

performance of total hip arthroplasty on a short-stay or

electrocautery [134].

day-case basis. Furthermore, the changes in surgical
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reduced

intrathecal morphine is the documented analgesia it

postoperative pain and more rapid recovery, are also

provides for at least 24 h postoperatively and the limited

considered.

adverse effects with small doses (≤ 0.1 mg morphine)

techniques,

which

have

allowed

for

We would like to emphasise that the previous literature

[147, 148]. However, pruritus and postoperative nausea

searches were performed between 1966 and July 2010,

and vomiting are associated with intrathecal morphine

while this one is performed between July 2010 and

[103, 113]. It was thought that even if the incidence of

December 2019. Of note, the databases searched and the

these adverse events may be relatively lower with

inclusion criteria for the reviews are identical, although the

intrathecal

PROSPECT methodology of interpretation of included

ambulation

studies has changed.

satisfaction [103, 113]. Indeed, adequate multimodal

There are signiﬁcant differences between these
updated

recommendations

recommendations

[11].

and

For

0.1 mg,

they

may

still

and oral intake, and inﬂuence

delay
patient

analgesia with paracetamol, NSAIDs and dexamethasone,

previous

without intrathecal morphine, together with more recent

previously

surgical techniques, may be sufﬁcient to provide patients

our

example,

morphine

recommended approaches such as femoral nerve block,

with good pain relief [145, 146, 149].

lumbar plexus block and epidural analgesia are no longer

Dexamethasone was not recommended in the previous

recommended due to the availability of evidence

guidelines due to limited procedure-speciﬁc evidence.

supporting better and safer alternatives such as fascia iliaca

However, based on recent evidence, dexamethasone 8–

block and LIA. In fact, even in the previous recommendation

10 mg i.v. is recommended. The safety of a single dose of

it was emphasised that lumbar plexus block provides

steroids is well documented [150, 151]. Equipotent doses of

superior pain relief to femoral nerve block, and that femoral

alternative glucocorticoids seem to be equally effective,

nerve block may have negative effects on postoperative

whereas

ambulation [11].

recommended due to insufﬁcient studies and concern

multiple

doses

beyond

24 h

are

not

Previously [11] LIA was not recommended due to

related to the potential side-effect proﬁle. Gabapentinoids

inconsistent evidence. In contrast, single injection LIA may

have shown opioid-sparing effects but can cause sedation;

now be considered based on supportive studies. The

blurred

PROSPECT

considerable

mobilisation; and cause orthostatic intolerance [152], and

heterogeneity and variability of published LIA studies with

thus are not recommended. Intra-operative ketamine is not

regard to analgesic effect, technique, volume and dose of

recommended due to limited procedure-speciﬁc evidence

local anaesthetic used and the drug combinations used

and potential psychotropic side-effects [153]. Neuraxial

Group

emphasises

the

vision;

dizziness

[41];

interfere

with

early

[77–92]. In addition, the studies are inconsistent with

anaesthesia has been recommended because it is

regard to the comparator groups (placebo vs. no injection

associated

vs. other analgesic technique) and single-shot or catheter

compared with general anaesthesia [5]. However, its

techniques. Also, in most studies of multi-drug LIA, there

beneﬁts with regard to postoperative pain control remains

was no control for potential systemic effects of the

inconclusive.

additives

in

the

mixtures.

The

PROSPECT

with

improved

postoperative

outcomes

Group

The limitations in this review are, among others, related

emphasises that with modern surgical techniques and the

to those of the included studies. Many of the analgesic

correct implementation of basic analgesia and multimodal

interventions were not evaluated against a control group

analgesia (paracetamol, NSAIDs and dexamethasone) the

that included an optimised multimodal analgesic regimen

added value of LIA techniques still warrant further

such as paracetamol and NSAIDs or COX-2-selective

validation [145, 146]. Therefore, the PROSPECT Group

inhibitors. There was considerable heterogeneity between

strongly encourages further well-conducted studies in this

studies such as unstandardised anaesthetic techniques,

area.

variable analgesic dosing regimens, variable methods of

There was signiﬁcant conﬂict amongst the PROSPECT

administration, variable control groups, as well as variable

members regarding the use of intrathecal morphine

time-points of pain assessments. Heterogeneous control

0.1 mg, and a consensus could not be reached. Delphi

groups were also documented by Karlsen et al. [154]. Other

voting revealed four members to be in favour of

limiting factors include selection bias by the primary

recommending the use of intrathecal morphine and nine

reviewers. Selection bias could have developed because all

members against. Therefore, if intrathecal morphine is

studies fulﬁlling the search requirements were split between

used, the PROSPECT Group reminds clinicians of the risks

two reviewers, and then included or excluded based on

and beneﬁts associated with its use. In favour of

Jadad score requirements. This method also allows for
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human error, where an appropriate study could have been
missed by a reviewer and excluded. Unfortunately, none of
the included studies assessed patients at high risk of
excessive postoperative pain (e.g. chronic opioid use,
chronic pain states or signiﬁcant psychiatric disorders). It is
possible that analgesic approaches not recommended in
this review due to limited analgesic efﬁcacy and/or
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Appendix 1. PROSPECT Working
Group
G. P. Joshi, E. Pogatzki-Zahn, M. Van de Velde, H. Kehlet, F.
Bonnet, N. Rawal, P. Lavand’homme, H. Beloeil, J. Raeder, A.
Sauter, E. Albrecht, P. Lirk, S. Freys, D. Lobo, T. Volk, M.
Werner, M. Bonnet.

concerns of adverse effects may be appropriate in situations
where one or more of the primary recommendations are
contraindicated or otherwise not appropriate to use. Also, it
may

be

appropriate

to

use

additional

analgesic

interventions beyond the primary recommendations in
patients with an anticipated higher than average risk of
strong postoperative pain (e.g. chronic opioid use, chronic
pain states or signiﬁcant psychiatric disorders).
In summary, this review has identiﬁed an analgesic
regimen for optimal pain management after elective total
hip arthroplasty (Table 1). We have also identiﬁed analgesic
interventions that are not recommended for routine pain
management in this patient population (Table 2). Future
studies should be adequately powered with standardised
anaesthetic regimens and use adequate basic analgesia to
account for discrepancies between treatment and control
groups. Focus should be on pain and appropriate analgesic
treatment in a short-stay context, as this is evolving as the
method of choice in terms of rapid rehabilitation.
Outcomes, such as time to ambulation, hospital length of
stay and the occurrence of chronic pain or chronic opioid
consumption should be included in the scope of future
studies, as these are closely related to the degree of
postoperative pain.
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